You are here

Drug Forecast

An Interleukin-5 Antagonist for Severe Asthma of the Eosinophilic Phenotype
A Mu-Opioid Receptor Agonist for the Treatment Of Irritable Bowel Syndrome With Diarrhea
A Treatment for Hallucinations and Delusions Associated With Parkinson’s Disease
The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women
A Substance P/Neurokinin-1 Receptor Antagonist for the Prevention of Chemotherapy-Induced Nausea and Vomiting
A Novel Adjunctive Therapy for Partial-Onset Seizures
A Treatment Option for Chronic Hepatitis C Infection